DOTA-TOC (DOTA-[Tyr3]-octreotide)


In stock


About DOTA-TOC (DOTA-[Tyr3]-octreotide)

DOTA-TOC (DOTA-[Tyr3]-octreotide), precursor for radiolabeled DOTA-TOC and ligand for somatostatin receptors. Can be bound to radionuclides for development of cancer treatment and diagnosis. For research use only!

DOTA-TOC (DOTA-[Tyr3]-octreotide) - Specifications

Amino acid sequence: DPhe-Cys-Tyr-DTrp-Lys-Thr-Cys-Thr-ol (cyclic disulfide)
Amount: 5 mg (50 x100µg)
Purity: >95% (HPLC-MS)
Delivery Format: Freeze-dried in glass vial
Application(s): Nuclear medicine
Condition(s)/Topic(s): Cancer
Standard Delivery Time: approx. 3 weeks

Are you interested in your other radoligands? Choose your sequence, amount and purity. We will assist you along the way. Custom Peptide Synthesis.

JPT's Single Catalog Peptides
JPT Peptide Technologies has substantial, long-standing expertise in providing custom peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All of JPT's catalogue peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

Benefits of JPT's Single Catalogue Peptides
- Whole production performed in a regulated European environment according to DIN EN ISO 9001:2015 & GCLP standards; audits welcome!
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies


References for DOTA-TOC (DOTA-[Tyr3]-octreotide)

Read References with Specialty Peptides

"Our group focuses on the in vitro study of risk factors in Alzheimer’s disease and, as we experienced that the in-house expression and production of the amyloid beta peptide is notoriously difficult, we are continuously dependent on a high quality supply of a large variety of these peptides from commercial source.We started our collaboration with JPT with their request to test a range of their peptides for the ability to produce toxic oligomers and fibrillar networks and were impressed by the rapid supply of a very wide range of high purity peptides with excellent fibril forming properties and toxicity profiles. JPT has shown real valuable know-how and experience in the field of peptide synthesis by their ability to generate high quality preparations of amyloid beta peptide variants which are known for their difficulty to handle."
Kerensa Broersen, Assistant Prof., Nanobiophysics Group, University of Twente, Enschede, The Netherlands


Documentation for DOTA-TOC (DOTA-[Tyr3]-octreotide)


Properties of DOTA-TOC (DOTA-[Tyr3]-octreotide)

Properties Values
Application: Nuclear medicine
Category: Chelate Peptides (DOTA)
Condition / Topic: Cancer
Layout: Freeze-dried in glass vial
Organism: Other/None
Protein Name: Other, Other;Selected proteins
Purity: >95% (HPLC-MS)
Quantification: Yes

Further Information to DOTA-TOC (DOTA-[Tyr3]-octreotide)

Information Values
Sequence: DPhe-Cys-Tyr-DTrp-Lys-Thr-Cys-Thr-ol (cyclic disulfide)
Specifications: DOTA-TOC (DOTA-[Tyr3]-octreotide)
TÜV Rheinland certified
Health - made in Germany
Quality Assurance

All production is ISO 9001:2015 certified.

Check our list of products, click and go.

Get a quote